Skip to content

Anti nosebleeds effect of Achillia ointment

The Assessment of Achillea millefolium ointment therapeutic effects on idiopathic recurrent epistaxis: A Randomized double blind clinical trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201410303186N6
Enrollment
50
Registered
2015-04-28
Start date
2014-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epistaxis. ??????? ????

Interventions

Intervention 1: Intervention group: vitamin A ointment is applied intranasal every other day with Achillia ointment for 10 days. Intervention 2: Control group: vitamin A ointment is applied intranasa
Treatment - Drugs
Placebo
Intervention group: vitamin A ointment is applied intranasal every other day with Achillia ointment for 10 days.
Control group: vitamin A ointment is applied intranasal every other day with placebo ointment for 10 days.

Sponsors

Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion critria: the patients who referred to the clinic of Besat hospital with recurrent epistaxis (minimum of 3 times per 2 months) and no specific etiology detect on history and physical exam Exclusion criteria: 1- Age under 12 and above 50 years old. 2- Pregnancy. 3- OCP use. 4- Hx of ischemic heart disease. 5- Hx of hypertension. 6- Hx of thromboamboli. 7- Hx of allergy to Achillia 8- Coagulation disorder.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Bleeding. Timepoint: Day 11th, fisrt month and third month after drug administration. Method of measurement: Epistaxis Severity score.

Secondary

MeasureTime frame
Adverse effect. Timepoint: Day 11th, first month and third month after drug administration. Method of measurement: History and clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactfarnaz hashemian

Hamadan University of Medical Sciences

hashemianf@yahoo.com, hashemian@umsha.ac.ir+98 81 3264 0063

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026